Public Health Emergency Medical Countermeasures Enterprise

Section 2811–1 of the Public Health Service Act (42 U.S.C. 300hh–10a) is amended— (1) in subsection (b)— (A) by redesignating paragraph (11) as paragraph (13); (B) by inserting after paragraph (10) the following: (11) The Director of the Biomedical Advanced Research and Development Authority. (12) The Director of the Strategic National Stockpile.; and (C) in paragraph (13), as so redesignated, by striking the Director of the Biomedical Advanced Research and Development Authority, the Director of the Strategic National Stockpile, the Director of the National Institute of Allergy and Infectious Diseases, and inserting the Director of the National Institute of Allergy and Infectious Diseases; and (2) in subsection (c)— (A) in paragraph (1)— (i) by redesignating subparagraph (D) as subparagraph (E); and (ii) by inserting after subparagraph (C) the following: (D) Assist the Secretary in developing strategies for appropriate and evidence-based allocation and distribution of countermeasures to jurisdictions, in a manner that supports the availability and use of such countermeasures, for public health and medical preparedness and response needs.; (B) in paragraph (2), by inserting relevant stakeholders, including industry, after consider input from; and (C) by adding at the end the following: (3) Information sharing The Secretary shall, as appropriate and in a manner that does not compromise national security, communicate and share information related to recommendations made and strategies developed under paragraph (1) with relevant stakeholders, including industry and State, local, and Tribal public health departments..